APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,256,000 | -6.5% | 1,400,000 | +124.0% | 7.10% | -8.3% |
| Q2 2023 | $56,937,500 | +7.9% | 625,000 | -21.9% | 7.74% | +2.5% |
| Q1 2023 | $52,768,000 | -24.4% | 800,000 | -40.7% | 7.55% | -7.7% |
| Q4 2022 | $69,808,500 | -21.4% | 1,350,000 | +3.8% | 8.18% | -25.1% |
| Q3 2022 | $88,790,000 | +30.9% | 1,300,000 | -13.3% | 10.92% | -12.3% |
| Q2 2022 | $67,830,000 | +48.3% | 1,500,000 | +66.7% | 12.44% | +109.9% |
| Q1 2022 | $45,729,000 | -3.3% | 900,000 | -10.0% | 5.93% | +21.6% |
| Q4 2021 | $47,280,000 | -1.1% | 1,000,000 | -31.0% | 4.88% | +41.5% |
| Q3 2021 | $47,792,000 | +116.1% | 1,450,000 | +314.3% | 3.45% | +85.4% |
| Q2 2021 | $22,120,000 | +28.9% | 350,000 | +16.7% | 1.86% | +26.4% |
| Q4 2020 | $17,160,000 | -4.5% | 300,000 | -48.9% | 1.47% | -66.8% |
| Q4 2019 | $17,977,000 | – | 587,108 | – | 4.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |